120 Participants Needed

CPAP for Premature Birth

(PLANT Trial)

Recruiting at 5 trial locations
BA
BA
ES
Overseen ByEdgardo Szyld, MD
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: University of Oklahoma
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I need to stop my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications.

Do I need to stop my current medications for this trial?

The trial information does not specify whether participants need to stop taking their current medications.

What data supports the idea that CPAP for Premature Birth is an effective treatment?

The available research shows that using CPAP in the delivery room for premature infants can reduce the need for more invasive procedures like intubation and mechanical ventilation. One study found that early use of CPAP in preterm infants improved outcomes compared to these more invasive methods. Another study indicated that CPAP could lower the risk of certain breathing problems and reduce the need for intensive care in newborns delivered by cesarean section. Overall, these findings suggest that CPAP is an effective treatment for helping premature babies breathe more easily right after birth.12345

What data supports the effectiveness of the treatment Continuous Positive Airway Pressure (CPAP) for premature birth?

Research shows that using CPAP early in the delivery room can reduce the need for more invasive breathing support, like intubation, in premature infants. It also helps improve breathing outcomes in newborns delivered by cesarean section and those born at or after 34 weeks of pregnancy.12345

What safety data exists for CPAP in premature birth treatment?

The provided research does not directly address safety data for CPAP in premature birth treatment. However, it highlights the importance of adverse event reporting and monitoring in healthcare settings, which is crucial for assessing the safety of any medical intervention, including CPAP. The studies emphasize the need for effective reporting systems and standard definitions for adverse events to improve patient safety, which can be applied to CPAP treatments as well.678910

Is CPAP generally safe for use in humans?

The research articles provided do not contain specific safety data about CPAP (Continuous Positive Airway Pressure) for premature birth or other conditions.678910

Is Continuous Positive Airway Pressure a promising treatment for premature birth?

Yes, Continuous Positive Airway Pressure (CPAP) is a promising treatment for premature birth. It can reduce the need for more invasive procedures like intubation and mechanical ventilation in premature infants. CPAP is increasingly used for initial respiratory support in preterm infants, especially those born before 32 weeks of gestation.1231112

How is the treatment CPAP for premature birth different from other treatments?

CPAP (Continuous Positive Airway Pressure) is unique because it provides gentle, continuous air pressure to keep a premature baby's airways open right from the delivery room, potentially reducing the need for more invasive procedures like intubation and mechanical ventilation.1231112

What is the purpose of this trial?

A Pragmatic Randomized Controlled Pilot Trial to Evaluate the Impact of Early Prophylactic Continuous Positive Airway Pressure with or without Supplemental Oxygen in Spontaneously Breathing Late Preterm Newborn Infants Born by Cesarean Delivery, Compared to No Early Prophylactic Continuous Positive Airway Pressure with or without Supplemental Oxygen, on the Need for Further Respiratory Support Leading to NICU Admissions.

Research Team

BA

Birju Shah, MD

Principal Investigator

Univeristy of Oklahoma Health Sciences Center

Eligibility Criteria

This trial is for late preterm infants born by C-section, specifically those with a gestational age between 34 and less than 37 weeks. Infants must be inborn (delivered at the hospital where the trial is conducted). Those with major congenital anomalies or conditions that severely limit life expectancy, such as pulmonary hypoplasia, cannot participate.

Inclusion Criteria

My newborn was delivered via Cesarean section.
My newborn was delivered via C-section between 34 and <37 weeks of pregnancy.
Gestational age between 34 weeks and < 37 weeks

Exclusion Criteria

Major congenital anomalies including pulmonary hypoplasia and lethal life-limiting conditions.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks
1 visit (in-person or virtual)

Treatment

Neonates receive either prophylactic DR-CPAP or standard care immediately after birth

First 30 minutes after birth
In-hospital monitoring

Follow-up

Participants are monitored for safety and effectiveness after treatment

Up to 30 days or until hospital discharge
Ongoing in-hospital monitoring

Treatment Details

Interventions

  • Continuous Positive Airway Pressure
  • Prophylactic Delivery Room Continuous Positive Airway Pressure
Trial Overview The study tests if giving early prophylactic Continuous Positive Airway Pressure (CPAP), with or without extra oxygen, to spontaneously breathing late preterm infants can reduce the need for additional respiratory support and NICU admissions compared to not using early CPAP.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Prophylactic Delivery Room Continuous Positive Airway PressureExperimental Treatment1 Intervention
If the infant is spontaneously breathing and allocated to the experimental arm, s/he will receive 20 min of 5 cm H2O of prophylactic continuous airway pressure using either a face mask or the appropriate size of nasal prong.
Group II: No Prophylactic Delivery Room Continuous Positive Airway PressureActive Control1 Intervention
Alternatively, spontaneously breathing infants assigned to control group will receive the standard of care with no prophylactic delivery room continuous positive airway pressure (CPAP). In both groups, CPAP can be used to help babies with persistent labored breathing or cyanosis after the initial steps as per the participating institution's neonatal resuscitation protocol. At any time, if the patient does not present spontaneous breathing, an escalation on the resuscitation measures will be performed and the study intervention will be terminated.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Oklahoma

Lead Sponsor

Trials
484
Recruited
95,900+

Indiana University

Collaborator

Trials
1,063
Recruited
1,182,000+

Pontificia Universidad Catolica de Chile

Collaborator

Trials
221
Recruited
165,000+

Columbia University

Collaborator

Trials
1,529
Recruited
2,832,000+

St. Louis University

Collaborator

Trials
197
Recruited
41,400+

University of Alberta

Collaborator

Trials
957
Recruited
437,000+

Findings from Research

In a study of 259 infants born at 35 weeks gestational age, those who received continuous positive airway pressure (CPAP) in the delivery room had a significantly higher risk of being admitted to the NICU, with a 9.3 times greater risk compared to those who did not receive CPAP.
The use of delivery room CPAP was strongly associated with respiratory conditions such as respiratory distress syndrome (RDS) and transient tachypnea of the newborn (TTN), indicating that while CPAP is commonly used, it may lead to increased neonatal morbidities.
What happens to 35 week infants that receive delivery room continuous positive airway pressure?Spillane, NT., Macalintal, F., Nyirenda, T., et al.[2021]
In a study of 151 premature infants with an average gestational age of 29.6 weeks, initiating continuous positive airway pressure (CPAP) immediately after birth significantly reduced the need for mechanical ventilation to 40%.
Only 13% of the infants required nasotracheal intubation, and the use of early CPAP was associated with a low incidence of pulmonary complications, supporting its role in decreasing neonatal morbidity.
[Early continuous positive pressure in the labor room].Millet, V., Lacroze, V., Bartoli, JM., et al.[2019]
Prophylactic continuous positive airway pressure (CPAP) significantly reduced the rate of NICU admissions for respiratory distress in newborns delivered by elective cesarean section, with 134 infants receiving CPAP showing a lower admission rate compared to 125 infants receiving standard care (p=0.045).
While the incidence of transient tachypnea of the newborn (TTN) was lower in the CPAP group, the difference was not statistically significant (p=0.059), indicating that CPAP may be beneficial but further research is needed to confirm its effects on TTN.
Impact of Prophylactic Continuous Positive Airway Pressure on Transient Tachypnea of the Newborn and Neonatal Intensive Care Admission in Newborns Delivered by Elective Cesarean Section.Celebi, MY., Alan, S., Kahvecioglu, D., et al.[2022]

References

What happens to 35 week infants that receive delivery room continuous positive airway pressure? [2021]
[Early continuous positive pressure in the labor room]. [2019]
Impact of Prophylactic Continuous Positive Airway Pressure on Transient Tachypnea of the Newborn and Neonatal Intensive Care Admission in Newborns Delivered by Elective Cesarean Section. [2022]
Early CPAP protocol in preterm infants with gestational age between 28 and 32 weeks: experience of a public hospital. [2021]
Continuous positive airway pressure for term and &#8805;34+0 weeks' gestation newborns at birth: A systematic review. [2022]
Effect of an anonymous reporting system on near-miss and harmful medical error reporting in a pediatric intensive care unit. [2022]
Development of standard definitions and grading for Maternal and Fetal Adverse Event Terminology. [2022]
Patient safety in South Africa: PICU adverse event registration*. [2014]
Risk, safety, and choice in childbirth. [2021]
Adverse events during nursing care procedure in intensive care unit: The PREVENIR study. [2021]
11.United Statespubmed.ncbi.nlm.nih.gov
Continuous positive airway pressure: current controversies. [2019]
Initial respiratory support modality and outcome in preterm infants with less than 32 weeks of gestation in China: A multicentre retrospective cohort study. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security